Alaunos Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-7.6M | $-25.2M | $-26.6M | $-17.9M | $-9.5M | $-5.7M |
| Depreciation & Amortization | $330.0K | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $2.2M | — | — | — | — | — |
| Net Cash from Operating Activities | $-12.3M | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditures | $11.0K | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-11.0K | — | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | $380.0K | — | — | — | — | — |
| Net Cash from Financing Activities | $49.8M | — | — | — | — | — |
| Net Change in Cash | $37.5M | — | — | — | — | — |
| Free Cash Flow | $-12.3M | — | — | — | — | — |